-
1
-
-
84870532473
-
Second infections independently increase mortality in hospitalized patients with cirrhosis: The North American consortium for the study of end-stage liver disease (NACSELD) experience
-
Bajaj, J. S. et al. Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience. Hepatology 56, 2328-2335 (2012).
-
(2012)
Hepatology
, vol.56
, pp. 2328-2335
-
-
Bajaj, J.S.1
-
2
-
-
84906793985
-
Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C
-
Elkrief, L. et al. Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C. Hepatology 60, 823-831, doi: 10.1002/hep.27228 (2014).
-
(2014)
Hepatology
, vol.60
, pp. 823-831
-
-
Elkrief, L.1
-
3
-
-
77958604153
-
High prevalence of diabetes mellitus in patients with liver cirrhosis
-
Wlazlo, N. et al. High prevalence of diabetes mellitus in patients with liver cirrhosis. Diabet Med 27, 1308-1311 (2010).
-
(2010)
Diabet Med
, vol.27
, pp. 1308-1311
-
-
Wlazlo, N.1
-
4
-
-
0033983645
-
Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease
-
Zein, N. N., Abdulkarim, A. S., Wiesner, R. H., Egan, K. S. & Persing, D. H. Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. Journal of hepatology 32, 209-217 (2000).
-
(2000)
Journal of Hepatology
, vol.32
, pp. 209-217
-
-
Zein, N.N.1
Abdulkarim, A.S.2
Wiesner, R.H.3
Egan, K.S.4
Persing, D.H.5
-
5
-
-
84856722705
-
Hospital readmissions among patients with decompensated cirrhosis
-
Volk, M. L., Tocco, R. S., Bazick, J., Rakoski, M. O. & Lok, A. S. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol 107, 247-252, doi: 10.1038/ajg.2011.314 (2012).
-
(2012)
Am J Gastroenterol
, vol.107
, pp. 247-252
-
-
Volk, M.L.1
Tocco, R.S.2
Bazick, J.3
Rakoski, M.O.4
Lok, A.S.5
-
6
-
-
84942022353
-
Decompensated cirrhosis and microbiome interpretation
-
Bajaj, J. S., Betrapally, N. S. & Gillevet, P. M. Decompensated cirrhosis and microbiome interpretation. Nature, doi: 10.1038/nature14851 (2015).
-
(2015)
Nature
-
-
Bajaj, J.S.1
Betrapally, N.S.2
Gillevet, P.M.3
-
7
-
-
84928580431
-
Is it time to target gut dysbiosis and immune dysfunction in the therapy of hepatic encephalopathy?
-
Shawcross, D. L. Is it time to target gut dysbiosis and immune dysfunction in the therapy of hepatic encephalopathy? Expert review of gastroenterology & hepatology 9, 539-542, doi: 10.1586/17474124.2015.1035257 (2015).
-
(2015)
Expert Review of Gastroenterology & Hepatology
, vol.9
, pp. 539-542
-
-
Shawcross, D.L.1
-
8
-
-
84907225684
-
Alterations of the human gut microbiome in liver cirrhosis
-
Qin, N. et al. Alterations of the human gut microbiome in liver cirrhosis. Nature, doi: 10.1038/nature13568 (2014).
-
(2014)
Nature
-
-
Qin, N.1
-
9
-
-
84867074831
-
A metagenome-wide association study of gut microbiota in type 2 diabetes
-
Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55-60, doi: 10.1038/nature11450 (2012).
-
(2012)
Nature
, vol.490
, pp. 55-60
-
-
Qin, J.1
-
10
-
-
84883181684
-
Human gut microbiota changes reveal the progression of glucose intolerance
-
Zhang, X. et al. Human gut microbiota changes reveal the progression of glucose intolerance. PloS one 8, e71108, doi: 10.1371/journal. pone.0071108 (2013).
-
(2013)
PloS One
, vol.8
-
-
Zhang, X.1
-
11
-
-
84884353768
-
An automated model using electronic medical record data identifies patients with cirrhosis at high risk for readmission
-
Singal, A. G. et al. An automated model using electronic medical record data identifies patients with cirrhosis at high risk for readmission. Clin Gastroenterol Hepatol 11, 1335-1341 e1331, doi: 10.1016/j.cgh.2013.03.022 (2013).
-
(2013)
Clin Gastroenterol Hepatol
, vol.11
, pp. 1335-1341
-
-
Singal, A.G.1
-
12
-
-
84922392216
-
Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function
-
Bajaj, J. S. et al. Systems Biology Analysis of Omeprazole Therapy in Cirrhosis Demonstrates Significant Shifts in Gut Microbiota Composition and Function. Am J Physiol Gastrointest Liver Physiol, doi: 10.1152/ajpgi.00268.2014 (2014).
-
(2014)
Am J Physiol Gastrointest Liver Physiol
-
-
Bajaj, J.S.1
-
13
-
-
79951687159
-
Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease
-
Berman, K. et al. Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease. Clin Gastroenterol Hepatol 9, 254-259, doi: 10.1016/j.cgh.2010.10.035 (2011).
-
(2011)
Clin Gastroenterol Hepatol
, vol.9
, pp. 254-259
-
-
Berman, K.1
-
14
-
-
84898830272
-
Altered profile of human gut microbiome is associated with cirrhosis and its complications
-
Bajaj, J. S. et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. Journal of hepatology 60, 940-947, doi: 10.1016/j.jhep.2013.12.019 (2014).
-
(2014)
Journal of Hepatology
, vol.60
, pp. 940-947
-
-
Bajaj, J.S.1
-
15
-
-
79960714764
-
Characterization of fecal microbial communities in patients with liver cirrhosis
-
Chen, Y. et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54, 562-572 (2011).
-
(2011)
Hepatology
, vol.54
, pp. 562-572
-
-
Chen, Y.1
-
16
-
-
84937890366
-
Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality
-
Chen, Y. et al. Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality. J Gastroenterol Hepatol, doi: 10.1111/jgh.12932 (2015).
-
(2015)
J Gastroenterol Hepatol
-
-
Chen, Y.1
-
17
-
-
84942553486
-
Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy
-
Bajaj, J. S. et al. Salivary Microbiota Reflects Changes in Gut Microbiota in Cirrhosis with Hepatic Encephalopathy. Hepatology, doi: 10.1002/hep.27819 (2015).
-
(2015)
Hepatology
-
-
Bajaj, J.S.1
-
18
-
-
79959496268
-
Diversity of the autochthonous colonic microbiota
-
Nava, G. M. & Stappenbeck, T. S. Diversity of the autochthonous colonic microbiota. Gut Microbes 2 (2011). doi: 10.4161/gmic.2.2.15416
-
(2011)
Gut Microbes
, vol.2
-
-
Nava, G.M.1
Stappenbeck, T.S.2
-
19
-
-
84876294967
-
Modulation of the fecal bile acid profile by gut microbiota in cirrhosis
-
Kakiyama, G. et al. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. Journal of hepatology 58, 949-955 (2013).
-
(2013)
Journal of Hepatology
, vol.58
, pp. 949-955
-
-
Kakiyama, G.1
-
20
-
-
84928171161
-
Cephalosporinases associated with outer membrane vesicles released by Bacteroides spp. Protect gut pathogens and commensals against beta-lactam antibiotics
-
Stentz, R. et al. Cephalosporinases associated with outer membrane vesicles released by Bacteroides spp. protect gut pathogens and commensals against beta-lactam antibiotics. J Antimicrob Chemother 70, 701-709, doi: 10.1093/jac/dku466 (2015).
-
(2015)
J Antimicrob Chemother
, vol.70
, pp. 701-709
-
-
Stentz, R.1
-
21
-
-
78650370258
-
Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial Clostridum difficile-associated disease
-
Manges, A. R. et al. Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial Clostridum difficile-associated disease. J Infect Dis 202, 1877-1884, doi: 10.1086/657319 (2010).
-
(2010)
J Infect Dis
, vol.202
, pp. 1877-1884
-
-
Manges, A.R.1
-
22
-
-
0344002716
-
Bacterial infection in cirrhotic patients and its relationship with alcohol
-
Rosa, H., Silverio, A. O., Perini, R. F. & Arruda, C. B. Bacterial infection in cirrhotic patients and its relationship with alcohol. Am J Gastroenterol 95, 1290-1293 (2000).
-
(2000)
Am J Gastroenterol
, vol.95
, pp. 1290-1293
-
-
Rosa, H.1
Silverio, A.O.2
Perini, R.F.3
Arruda, C.B.4
-
23
-
-
84862276328
-
Structure, function and diversity of the healthy human microbiome
-
Human Microbiome Project, C. Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214, doi: 10.1038/nature11234 (2012).
-
(2012)
Nature
, vol.486
, pp. 207-214
-
-
Human Microbiome Project, C,1
-
24
-
-
84856957894
-
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
-
Henao-Mejia, J. et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179-185, doi: 10.1038/nature10809 (2012).
-
(2012)
Nature
, vol.482
, pp. 179-185
-
-
Henao-Mejia, J.1
-
25
-
-
69249166158
-
Secondary prophylaxis of hepatic encephalopathy: An open-label randomized controlled trial of lactulose versus placebo
-
891 e881
-
Sharma, B. C., Sharma, P., Agrawal, A. & Sarin, S. K. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo. Gastroenterology 137, 885-891, 891 e881, doi: 10.1053/j.gastro.2009.05.056 (2009).
-
(2009)
Gastroenterology
, vol.137
, pp. 885-891
-
-
Sharma, B.C.1
Sharma, P.2
Agrawal, A.3
Sarin, S.K.4
-
26
-
-
84875670330
-
Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy
-
Bajaj, J. S. et al. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PloS one 8, e60042, doi: 10.1371/journal.pone.0060042 (2013).
-
(2013)
PloS One
, vol.8
-
-
Bajaj, J.S.1
-
27
-
-
77950246404
-
Rifaximin treatment in hepatic encephalopathy
-
Bass, N. M. et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med 362, 1071-1081, doi: 10.1056/NEJMoa0907893 (2010).
-
(2010)
N Engl J Med
, vol.362
, pp. 1071-1081
-
-
Bass, N.M.1
-
28
-
-
84913553798
-
Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: A randomized, controlled trial
-
Dhiman, R. K. et al. Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial. Gastroenterology 147, 1327-1337 e1323, doi: 10.1053/j.gastro.2014.08.031 (2014).
-
(2014)
Gastroenterology
, vol.147
, pp. 1327-1337
-
-
Dhiman, R.K.1
-
29
-
-
84912544732
-
Gut microbiota and metabolic syndrome
-
Festi, D. et al. Gut microbiota and metabolic syndrome. World J Gastroenterol 20, 16079-16094, doi: 10.3748/wjg.v20.i43.16079 (2014).
-
(2014)
World J Gastroenterol
, vol.20
, pp. 16079-16094
-
-
Festi, D.1
-
30
-
-
33845901507
-
Microbial ecology: Human gut microbes associated with obesity
-
Ley, R. E., Turnbaugh, P. J., Klein, S. & Gordon, J. I. Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023, doi: 10.1038/4441022a (2006).
-
(2006)
Nature
, vol.444
, pp. 1022-1023
-
-
Ley, R.E.1
Turnbaugh, P.J.2
Klein, S.3
Gordon, J.I.4
-
31
-
-
78649908827
-
The role of the gut microbiota in nonalcoholic fatty liver disease
-
Abu-Shanab, A. & Quigley, E. M. The role of the gut microbiota in nonalcoholic fatty liver disease. Nature reviews. Gastroenterology & hepatology 7, 691-701, doi: 10.1038/nrgastro.2010.172 (2010).
-
(2010)
Nature Reviews. Gastroenterology & Hepatology
, vol.7
, pp. 691-701
-
-
Abu-Shanab, A.1
Quigley, E.M.2
-
32
-
-
0034106289
-
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
-
Malinchoc, M. et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31, 864-871, doi: 10.1053/he.2000.5852 (2000).
-
(2000)
Hepatology
, vol.31
, pp. 864-871
-
-
Malinchoc, M.1
-
33
-
-
84925198306
-
Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis
-
e751-752
-
O'Leary, J. G. et al. Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis. Clin Gastroenterol Hepatol 13, 753-759 e751-752, doi: 10.1016/j.cgh.2014.07.060 (2015).
-
(2015)
Clin Gastroenterol Hepatol
, vol.13
, pp. 753-759
-
-
O'Leary, J.G.1
-
34
-
-
84878562423
-
Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis
-
Bajaj, J. S., Ratliff, S. M., Heuman, D. M. & Lapane, K. L. Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis. Aliment Pharmacol Ther 36, 866-874, doi: 10.1111/apt.12045 (2012).
-
(2012)
Aliment Pharmacol Ther
, vol.36
, pp. 866-874
-
-
Bajaj, J.S.1
Ratliff, S.M.2
Heuman, D.M.3
Lapane, K.L.4
-
35
-
-
84942309351
-
Are proton pump inhibitors affecting intestinal microbiota health?
-
Melgar, S. & Nieuwdorp, M. Are Proton Pump Inhibitors Affecting Intestinal Microbiota Health? Gastroenterology, doi: 10.1053/j. gastro.2015.08.039 (2015).
-
(2015)
Gastroenterology
-
-
Melgar, S.1
Nieuwdorp, M.2
-
36
-
-
77950626219
-
Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis
-
Appenrodt, B. et al. Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis. Hepatology 51, 1327-1333, doi: 10.1002/hep.23440 (2010).
-
(2010)
Hepatology
, vol.51
, pp. 1327-1333
-
-
Appenrodt, B.1
-
37
-
-
79959383523
-
Metagenomic biomarker discovery and explanation
-
Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol 12, R60, doi: 10.1186/gb-2011-12-6-r60 (2011).
-
(2011)
Genome Biol
, vol.12
, pp. R60
-
-
Segata, N.1
-
38
-
-
84866396844
-
Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation
-
Bajaj, J. S. et al. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am J Physiol Gastrointest Liver Physiol 303, G675-685, doi: 10.1152/ajpgi.00152.2012 (2012).
-
(2012)
Am J Physiol Gastrointest Liver Physiol
, vol.303
, pp. G675-685
-
-
Bajaj, J.S.1
-
39
-
-
77952771845
-
Quantitative assessment of the human gut microbiome using multitag pyrosequencing
-
Gillevet, P., Sikaroodi, M., Keshavarzian, A. & Mutlu, E. A. Quantitative assessment of the human gut microbiome using multitag pyrosequencing. Chem Biodivers 7, 1065-1075 (2010).
-
(2010)
Chem Biodivers
, vol.7
, pp. 1065-1075
-
-
Gillevet, P.1
Sikaroodi, M.2
Keshavarzian, A.3
Mutlu, E.A.4
-
40
-
-
67650021209
-
Microbial community profiling for human microbiome projects: Tools, techniques, and challenges
-
Hamady, M. & Knight, R. Microbial community profiling for human microbiome projects: Tools, techniques, and challenges. Genome Res 19, 1141-1152 (2009).
-
(2009)
Genome Res
, vol.19
, pp. 1141-1152
-
-
Hamady, M.1
Knight, R.2
-
41
-
-
66249145772
-
Statistical methods for detecting differentially abundant features in clinical metagenomic samples
-
White, J. R., Nagarajan, N. & Pop, M. Statistical methods for detecting differentially abundant features in clinical metagenomic samples. PLoS Comput Biol 5, e1000352 (2009).
-
(2009)
PLoS Comput Biol
, vol.5
-
-
White, J.R.1
Nagarajan, N.2
Pop, M.3
|